. . .

Notable News to Watch: Amyris (NASDAQ:AMRS)

Amyris (NASDAQ:AMRS) stock observed trading -49.49% off 52-week high price. On the other end, the stock has been noted 150.80% away from low price over the last 52-weeks. The stock disclosed a move of 21.14% away from 50 day moving average and 21.78% away from 200 day moving average. Moving closer, we can see that shares have been trading 4.37% off 20-day moving average. It has market cap of $335.9M.

 On Oct. 1, 2019,  Amyris (NASDAQ:AMRS)  provided highlights of its business and financial results for the first half of 2019 ended June 30, 2019, which it will review during a conference call after market close on Wednesday, October 2, 2019. The company also noted that it is has filed its 2018 Form 10-K and expects to file its Form 10-Qs for the first and second quarters of 2019 before the conference call on Wednesday. As a result of completing these filings, the company believes that it will have filed all of its delinquent SEC filings and be back in compliance with NASDAQ listing rules.

First-Half 2019 Financial Results and Recent Business Highlights

  • First-half 2019 GAAP revenue of $77.1 million with very strong gross margin compared to total first-half 2018 GAAP revenue of $32.9 million
  • Successful launch of Pipette baby care brand raising the bar for clean and safe baby care products
  • International expansion of Biossance, one of the fastest growing clean beauty skincare brands in the US, gets a strong start upon entry into Australian and New Zealand markets
  • Expansion of ADL Bionatur Solutions (ADL) manufacturing agreement and execution of strategic supply agreement with Raízen, the largest sugar producer in the world, to provide additional, cost-effective manufacturing capacity to meet growth demand
  • Appointment of two new board members with significant experience in building high growth product and consumer companies ‒ Jim McCann, founder and chairman of 1-800-Flowers, and Lisa Qi, founder and CEO of Daling Family e-commerce platform in China
  • Receipt of first milestone payment of $10 million in March 2019 for successful cannabinoid (CBD) development; good progress being made toward second major milestone

The USA based company Amyris moved with change of -1.47% to $4.69 with the total traded volume of 1981979 shares in recent session versus to an average volume of 818.78K. The stock was observed in the 5 days activity at 3.08%. The one month performance of stock was 24.07%. AMRS’s shares are at 33.62% for the quarter and driving a -40.93% return over the course of the past year and is now at 40.42% since this point in 2018.  Right now the stock beta is 0.94. The average volatility for the week and month was at 8.54% and 7.65% respectively. There are 71.62M shares outstanding and 32.83M shares are floated in market.

Leave a Reply

Your email address will not be published. Required fields are marked *